Stocks Overview

LAST PRICE
27.9600
TODAY'S CHANGE (%)
Trending Up0.3900 (1.4146%)

Bid / Lots
26.1000/ 1
Ask / Lots
28.0900/ 1
Open / Previous Close
27.8100 / 27.5700
Day Range
Low 27.4500
High 28.2000
52 Week Range
Low 16.0400
High 28.3200
Volume
1,881,967
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 27.57
Time	Volume	INSM
09:32 ET	19331	27.765
09:33 ET	10743	27.9
09:35 ET	8655	28.01
09:37 ET	47363	28.165
09:39 ET	5624	27.995
09:42 ET	24293	28.105
09:44 ET	10064	28
09:46 ET	6958	28.01
09:48 ET	7719	28.11
09:50 ET	13858	28.15
09:51 ET	2600	28.12
09:53 ET	18932	27.91
09:55 ET	3700	27.765
09:57 ET	1000	27.84
10:00 ET	2200	27.84
10:02 ET	12384	27.925
10:04 ET	7095	27.94
10:06 ET	3072	27.92
10:08 ET	1737	27.965
10:09 ET	3382	27.95
10:11 ET	2373	27.915
10:13 ET	1500	27.88
10:15 ET	3610	27.9
10:18 ET	4800	27.89
10:20 ET	2000	27.9
10:22 ET	2607	27.855
10:24 ET	1200	27.88
10:26 ET	3590	27.95
10:27 ET	2728	27.92
10:29 ET	200	27.915
10:31 ET	3183	27.87
10:33 ET	2179	27.785
10:36 ET	3269	27.745
10:38 ET	3700	27.62
10:40 ET	6134	27.67
10:42 ET	400	27.665
10:44 ET	400	27.72
10:45 ET	3243	27.79
10:47 ET	5652	27.795
10:49 ET	2170	27.745
10:51 ET	13488	27.805
10:54 ET	30560	27.79
10:56 ET	2880	27.765
10:58 ET	900	27.74
11:00 ET	27410	27.64
11:02 ET	6124	27.745
11:03 ET	1400	27.78
11:05 ET	2865	27.73
11:07 ET	2315	27.8
11:09 ET	3556	27.74
11:12 ET	1169	27.69
11:14 ET	4357	27.62
11:16 ET	1269	27.62
11:18 ET	3150	27.545
11:20 ET	1398	27.525
11:21 ET	42156	27.65
11:23 ET	8741	27.59
11:25 ET	846	27.55
11:27 ET	2400	27.55
11:30 ET	4269	27.53
11:32 ET	17765	27.55
11:34 ET	4312	27.575
11:36 ET	1200	27.59
11:38 ET	3900	27.59
11:39 ET	2900	27.57
11:41 ET	2497	27.495
11:43 ET	4204	27.47
11:45 ET	2900	27.54
11:48 ET	4549	27.525
11:50 ET	3549	27.48
11:52 ET	1700	27.49
11:54 ET	15179	27.57
11:56 ET	5475	27.56
11:57 ET	3200	27.6
11:59 ET	2520	27.665
12:01 ET	4212	27.68
12:03 ET	2400	27.65
12:06 ET	2400	27.61
12:08 ET	1400	27.615
12:10 ET	2304	27.625
12:12 ET	800	27.585
12:14 ET	900	27.55
12:15 ET	2794	27.54
12:17 ET	3438	27.585
12:19 ET	2500	27.575
12:21 ET	1730	27.575
12:24 ET	1000	27.51
12:26 ET	1976	27.52
12:28 ET	1300	27.55
12:30 ET	1900	27.6
12:32 ET	3312	27.57
12:33 ET	781	27.56
12:35 ET	1134	27.57
12:37 ET	600	27.56
12:39 ET	609	27.575
12:42 ET	11354	27.61
12:44 ET	1182	27.61
12:46 ET	6424	27.655
12:48 ET	2603	27.6
12:50 ET	2445	27.64
12:51 ET	1300	27.64
12:53 ET	1900	27.62
12:55 ET	1700	27.69
12:57 ET	3200	27.7
01:00 ET	2479	27.76
01:02 ET	16698	27.75
01:04 ET	2163	27.725
01:06 ET	1800	27.73
01:08 ET	4247	27.69
01:09 ET	1108	27.73
01:11 ET	300	27.75
01:13 ET	1889	27.78
01:15 ET	2790	27.78
01:18 ET	1348	27.8
01:20 ET	800	27.8
01:22 ET	2353	27.79
01:24 ET	2867	27.82
01:26 ET	3425	27.83
01:27 ET	4520	27.855
01:29 ET	3833	27.87
01:31 ET	2988	27.825
01:33 ET	900	27.83
01:36 ET	5338	27.8375
01:38 ET	1904	27.85
01:40 ET	4400	27.84
01:42 ET	2980	27.795
01:44 ET	1154	27.8
01:45 ET	4870	27.81
01:47 ET	1400	27.815
01:49 ET	3472	27.74
01:51 ET	608	27.76
01:54 ET	1779	27.78
01:56 ET	4000	27.79
01:58 ET	3713	27.765
02:00 ET	2213	27.75
02:02 ET	3989	27.695
02:03 ET	4345	27.68
02:05 ET	2750	27.73
02:07 ET	1100	27.75
02:09 ET	1600	27.75
02:12 ET	18115	27.81
02:14 ET	1700	27.79
02:16 ET	3200	27.79
02:18 ET	2661	27.815
02:20 ET	2000	27.81
02:21 ET	1960	27.83
02:23 ET	3876	27.82
02:25 ET	2345	27.785
02:27 ET	800	27.795
02:30 ET	6579	27.85
02:32 ET	3029	27.84
02:34 ET	100	27.825
02:36 ET	2269	27.85
02:38 ET	1455	27.85
02:39 ET	2388	27.84
02:41 ET	3337	27.87
02:43 ET	4300	27.85
02:45 ET	2595	27.81
02:48 ET	1736	27.83
02:50 ET	5083	27.825
02:52 ET	2948	27.845
02:54 ET	1200	27.86
02:56 ET	1000	27.85
02:57 ET	2628	27.855
02:59 ET	2933	27.86
03:01 ET	3302	27.82
03:03 ET	1606	27.82
03:06 ET	3344	27.82
03:08 ET	2058	27.82
03:10 ET	2179	27.84
03:12 ET	3316	27.83
03:14 ET	7783	27.87
03:15 ET	3831	27.87
03:17 ET	1500	27.905
03:19 ET	4041	27.855
03:21 ET	3078	27.87
03:24 ET	3264	27.88
03:26 ET	2730	27.89
03:28 ET	6671	27.9
03:30 ET	23848	27.955
03:32 ET	6648	27.935
03:33 ET	9526	27.955
03:35 ET	1400	27.9
03:37 ET	8171	27.91
03:39 ET	20275	28
03:42 ET	14677	27.995
03:44 ET	8542	28.055
03:46 ET	6899	28.06
03:48 ET	17245	28.03
03:50 ET	9791	27.995
03:51 ET	19732	28
03:53 ET	17558	27.985
03:55 ET	22345	28
03:57 ET	48428	27.99
04:00 ET	290690	27.96

Data delayed at least 15 minutes.

Dec 5, 2023
- Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), from 8:00AM ET on Tuesday Dec 05, 2023 by Dow Jones
  8:00AM ET on Tuesday Dec 05, 2023 by Dow Jones
Nov 29, 2023
- Insmed To Present at the Nasdaq 49th Investor Conference, from 8:00AM ET on Wednesday Nov 29, 2023 by Dow Jones
  8:00AM ET on Wednesday Nov 29, 2023 by Dow Jones
Nov 20, 2023
- DJ Insmed Price Target Announced at $36.00/Share by JP Morgan, from 8:06AM ET on Monday Nov 20, 2023 by Dow Jones
  8:06AM ET on Monday Nov 20, 2023 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesINSM Insmed Inc	3.9B	-5.3x	---
United StatesIMCR Immunocore Holdings PLC	2.7B	-40.9x	---
United StatesBPMC Blueprint Medicines Corp	4.5B	-8.0x	---
United StatesFOLD Amicus Therapeutics Inc	3.4B	-18.9x	---
United StatesRVMD Revolution Medicines Inc	4.0B	-7.5x	---
United StatesMRTX Mirati Therapeutics Inc	4.0B	-4.6x	---
As of 2023-12-09

Insmed Incorporated is a biopharmaceutical company. It is engaged in providing ARIKAYCE (amikacin liposome inhalation suspension) product, which is used for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1, which is developed for the treatment of patients with bronchiectasis, cystic fibrosis (CF) and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRS) and hidradenitis suppurativa (HS). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil which offers a differentiated product profile for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Contact Information

Headquarters: 700 Us Highway 202/206BRIDGEWATER, NJ, United States 08807
Phone: 908-977-9900
Fax: ---

Executives

Chairman of the Board, President, Chief Executive Officer: William Lewis
Chief Financial Officer: Sara Bonstein
Chief Operating Officer: Roger Adsett
Chief People Strategy Officer: S. Nicole Schaeffer
Senior Vice President, General Counsel, Corporate Secretary: Michael Smith

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

Fundamentals Table
Market Cap	$3.9B
Revenue (TTM)	$280.8M
Shares Outstanding	143.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	1.22
EPS	$-5.27
Book Value	$0.65
P/E Ratio	-5.3x
Price/Sales (TTM)	14.0
Price/Cash Flow (TTM)	---
Operating Margin	-243.16%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Insmed Inc
NASDAQ:INSMUnited States

Search Criteria

Charts

Recent News

Dec 5, 2023

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4), from 8:00AM ET on Tuesday Dec 05, 2023 by Dow Jones

Nov 29, 2023

Insmed To Present at the Nasdaq 49th Investor Conference, from 8:00AM ET on Wednesday Nov 29, 2023 by Dow Jones

Nov 20, 2023

DJ Insmed Price Target Announced at $36.00/Share by JP Morgan, from 8:06AM ET on Monday Nov 20, 2023 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar